SCOPUS 정보 검색 플랫폼

Journal of Clinical Oncology

Volumn 30, Issue 16, 2012, Pages

Acquired angioedema and marginal zone lymphoma

(5) Lam, David H a Levy, Norman B b Nickerson, James M c Gruenberg, David A b Lansigan, Frederick b

a DARTMOUTH MEDICAL SCHOOL (United States)

b DARTMOUTH HITCHCOCK MEDICAL CENTER (United States)

c NORRIS COTTON CANCER CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; RITUXIMAB;

AGED; ANAMNESIS; ANGIONEUROTIC EDEMA; ARTICLE; ASCITES; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MAINTENANCE THERAPY; MARGINAL ZONE LYMPHOMA; PANCYTOPENIA; PRIORITY JOURNAL; SPLENOMEGALY; TREATMENT OUTCOME;

ABDOMINAL PAIN; AGED, 80 AND OVER; ANGIOEDEMA; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; SPLENOMEGALY;

EID: 84863942410 PISSN: 0732183X EISSN: 15277755 Source Type: Journal
DOI: 10.1200/JCO.2011.38.9957 Document Type: Article

Times cited : (24)

References (15)

1
- 33745402382
- Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone
- DOI 10.1002/cncr.21931
- Tsimberidou AM, Catovsky D, Schlette E, et al: Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone. Cancer 107: 125-135, 2006 (Pubitemid 43941641)
- (2006) Cancer , vol.107 , Issue.1 , pp. 125-135
- Tsimberidou, A.M.¹ Catovsky, D.² Schlette, E.³ O'Brien, S.⁴ Wierda, W.G.⁵ Kantarjian, H.⁶ Garcia-Manero, G.⁷ Wen, S.⁸ Do, K.-A.⁹ Lerner, S.¹⁰ Keating, M.J.¹¹

2
- 34848837286
- Rituximab monotherapy is highly effective in splenic marginal zone lymphoma
- DOI 10.1002/hon.820
- Kalpadakis C, Pangalis GA, Dimopoulou MN, et al: Rituximab monotherapy is highly effective in splenic marginal zone lymphoma. Hematol Oncol 25:127-131, 2007 (Pubitemid 47507880)
- (2007) Hematological Oncology , vol.25 , Issue.3 , pp. 127-131
- Kalpadakis, C.¹ Pangalis, G.A.² Dimopoulou, M.N.³ Vassilakopoulos, T.P.⁴ Kyrtsonis, M.-C.⁵ Korkolopoulou, P.⁶ Kontopidou, F.N.⁷ Siakantaris, M.P.⁸ Dimitriadou, E.M.⁹ Kokoris, S.I.¹⁰ Tsaftaridis, P.¹¹ Plata, E.¹² Angelopoulou, M.K.¹³

3
- 77950325091
- Treatment of splenic marginal zone lymphoma: Splenectomy versus rituximab
- Bennett M, Schechter GP: Treatment of splenic marginal zone lymphoma: Splenectomy versus rituximab. Semin Hematol 47:143-147, 2010
- (2010) Semin Hematol , vol.47 , pp. 143-147
- Bennett, M.¹ Schechter, G.P.²

4
- 0037320989
- Splenic marginal-zone lymphoma: A distinct clinical and pathological entity
- DOI 10.1016/S1470-2045(03)00981-1
- Thieblemont C, Felman P, Callet-Bauchu E, et al: Splenic marginal-zone lymphoma: A distinct clinical and pathological entity. Lancet Oncol 4:95-103, 2003 (Pubitemid 36193169)
- (2003) Lancet Oncology , vol.4 , Issue.2 , pp. 95-103
- Thieblemont, C.¹ Felman, P.² Callet-Bauchu, E.³ Traverse-Glehen, A.⁴ Salles, G.⁵ Berger, F.⁶ Coiffier, B.⁷

5
- 33750531675
- Acquired Deficiency of the Inhibitor of the First Complement Component: Presentation, Diagnosis, Course, and Conventional Management
- DOI 10.1016/j.iac.2006.08.002, PII S0889856106000750, Angioedema
- Zingale LC, Castelli R, Zanichelli A, et al: Acquired deficiency of the inhibitor of the first complement component: Presentation, diagnosis, course, and conventional management. Immunol Allergy Clin North Am 26:669-690, 2006 (Pubitemid 44666305)
- (2006) Immunology and Allergy Clinics of North America , vol.26 , Issue.4 , pp. 669-690
- Zingale, L.C.¹ Castelli, R.² Zanichelli, A.³ Cicardi, M.⁴

6
- 79952410458
- Acquired angioedema
- Cicardi M, Zanichelli A: Acquired angioedema. Allergy Asthma Clin Immunol 6:14, 2010
- (2010) Allergy Asthma Clin Immunol , vol.6 , pp. 14
- Cicardi, M.¹ Zanichelli, A.²

7
- 0038161137
- Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies
- DOI 10.1097/00005792-200307000-00006
- Cicardi M, Zingale LC, Pappalardo E, et al: Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies. Medicine (Baltimore) 82:274-281, 2003 (Pubitemid 36859223)
- (2003) Medicine , vol.82 , Issue.4 , pp. 274-281
- Cicardi, M.¹ Zingale, L.C.² Pappalardo, E.³ Folcioni, A.⁴ Agostoni, A.⁵

8
- 0018903514
- Acquired angioedema, autoimmune hemolytic anemia, and lymphoma: Resolution after therapy
- Fiechtner JJ, Marx JJ Jr, Wolski KP, et al: Acquired angioedema, autoimmune hemolytic anemia, and lymphoma: Resolution after therapy. Clin Immunol Immunopathol 15:642-645, 1980 (Pubitemid 10181907)
- (1980) Clinical Immunology and Immunopathology , vol.15 , Issue.4 , pp. 642-645
- Fiechtner, J.J.¹ Marx Jr., J.J.² Wolski, K.P.³ Schloesser, L.L.⁴

9
- 0027437955
- Acquired angioedema as the presenting feature of lymphoproliferative disorders of mature B-lymphocytes
- DOI 10.1002/1097-0142(19931201)72:11<3318::AID-CNCR2820721130>3.0. CO;2-N
- Bain BJ, Catovsky D, Ewan PW: Acquired angioedema as the presenting feature of lymphoproliferative disorders of mature B-lymphocytes. Cancer 72: 3318-3322, 1993 (Pubitemid 23356779)
- (1993) Cancer , vol.72 , Issue.11 , pp. 3318-3322
- Bain, B.J.¹ Catovsky, D.² Ewan, P.W.³

10
- 56349101289
- Angioedema due to acquired C1-inhibitor deficiency: A bridging condition between autoimmunity and lymphoproliferation
- Cugno M, Castelli R, Cicardi M: Angioedema due to acquired C1-inhibitor deficiency: A bridging condition between autoimmunity and lymphoproliferation. Autoimmun Rev 8:156-159, 2008
- (2008) Autoimmun Rev , vol.8 , pp. 156-159
- Cugno, M.¹ Castelli, R.² Cicardi, M.³

11
- 27844576675
- Acquired angioedema: A new target for rituximab?
- Ziakas PD, Giannouli S, Psimenou E, et al: Acquired angioedema: A new target for rituximab? Haematologica 89:104-105, 2004
- (2004) Haematologica , vol.89 , pp. 104-105
- Ziakas, P.D.¹ Giannouli, S.² Psimenou, E.³

12
- 33746447184
- Rituximab-induced Elimination of Acquired Angioedema Due to C1-Inhibitor Deficiency
- DOI 10.1016/j.amjmed.2005.09.018, PII S0002934305008600
- Levi M, Hack CE, van Oers MH: Rituximab-induced elimination of acquired angioedema due to C1-inhibitor deficiency. Am J Med 119:e3-e5, 2006 (Pubitemid 44128437)
- (2006) American Journal of Medicine , vol.119 , Issue.8
- Levi, M.¹ Hack, C.E.² Van Oers, M.H.³

13
- 25444437442
- Rituximab treatment in patients with primary Sjögren's syndrome: An open-label phase II study
- DOI 10.1002/art.21260
- Pijpe J, van Imhoff GW, Spijkervet FK, et al: Rituximab treatment in patients with primary Sjögren's syndrome: An open-label phase II study. Arthritis Rheum 52:2740-2750, 2005 (Pubitemid 41369102)
- (2005) Arthritis and Rheumatism , vol.52 , Issue.9 , pp. 2740-2750
- Pijpe, J.¹ Van Imhoff, G.W.² Spijkervet, F.K.L.³ Roodenburg, J.L.N.⁴ Wolbink, G.J.⁵ Mansour, K.⁶ Vissink, A.⁷ Kallenberg, C.G.M.⁸ Bootsma, H.⁹

14
- 77954868227
- Controversies on rituximab therapy in Sjögren syndrome-associated lymphoproliferation
- Quartuccio L, Fabris M, Salvin S, et al: Controversies on rituximab therapy in Sjögren syndrome-associated lymphoproliferation. Int J Rheumatol 424935, 2009
- (2009) Int J Rheumatol , pp. 424935
- Quartuccio, L.¹ Fabris, M.² Salvin, S.³

15
- 79251647230
- Transition of thyroid autoantibodies by rituximab treatment for thyroid MALT lymphoma
- Kahara T, Iwaki N, Kaya H, et al: Transition of thyroid autoantibodies by rituximab treatment for thyroid MALT lymphoma. Endocr J 58:7-12, 2011
- (2011) Endocr J , vol.58 , pp. 7-12
- Kahara, T.¹ Iwaki, N.² Kaya, H.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.